体重指数升高是否影响不孕患者子宫内膜基因表达模式?一项功能基因组学分析
该多中心前瞻性病例对照研究在不孕女性标准雌孕激素替代周期后取子宫内膜,用微阵列分析发现肥胖组种植窗期XCL1、XCL2、HMHA1、S100A1、KLRC1、COTL1、COL16A1、KRT7和MFAP5表达显著失调,结论认为肥胖与子宫内膜转录组差异相关,可能贡献于较低种植率和较高流产率。
要点
- 肥胖不孕患者种植窗期子宫内膜XCL1、XCL2、HMHA1、KRCL1、COTL1、COL16A1下调,KRT7、MFAP5、S100A1上调。
- 差异基因主要涉及趋化因子、细胞因子、免疫系统活性及细胞外基质与蛋白结合功能。
- 肥胖与子宫内膜转录组显著差异相关,可能贡献于较低种植率和较高流产率。
核心结论
- 肥胖与非肥胖受试者相比存在显著的子宫内膜转录组差异。
- 肥胖患者子宫内膜基因表达改变可能贡献于肥胖不孕患者中观察到的较低种植率和较高流产率。
研究设计与样本
- 多中心、前瞻性、病例对照研究,设置于三个生殖医学学术医疗中心。
- 不孕患者按世界卫生组织指南的体重指数(BMI)分类进行分层。
- 子宫内膜样本取自接受标准化雌激素和孕激素替代周期、经阴道孕激素补充5天后的女性。
- 采用微阵列分析比较肥胖不孕患者与正常体重不孕对照在种植窗期的子宫内膜基因表达改变。
主要发现
- XCL1、XCL2、HMHA1、S100A1、KLRC1、COTL1、COL16A1、KRT7和MFAP5在肥胖患者接受期子宫内膜种植窗期显著失调。
- COL16A1、COTL1、HMHA1、KRCL1、XCL1和XCL2在肥胖患者子宫内膜中下调。
- KRT7、MFAP5和S100A1在肥胖患者子宫内膜中上调。
- 这些基因主要参与趋化因子、细胞因子和免疫系统活性以及结构性细胞外基质和蛋白结合分子功能。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To analyze the transcriptomic profile of endometrial gene alterations during the window of implantation in infertile obese patients. DESIGN: Multicenter, prospective, case-control study. SETTING: Three academic medical centers for reproductive medicine. PATIENT(S): Infertile patients, stratified into body mass index (BMI) categories according to the World Health Organization guidelines, were included in the study. INTERVENTION(S): Endometrial samples were obtained from women undergoing standardized estrogen and P replacement cycles after 5 days of vaginal P supplementation. MAIN OUTCOME MEASURE(S): To identify endometrial gene expression alterations that occur during the window of implantation in infertile obese patients as compared with infertile normal-weight controls using a microarray analysis. RESULT(S): XCL1, XCL2, HMHA1, S100A1, KLRC1, COTL1, COL16A1, KRT7, and MFAP5 are significantly dysregulated during the window of implantation in the receptive endometrium of obese patients. COL16A1, COTL1, HMHA1, KRCL1, XCL1, and XCL2 were down-regulated and KRT7, MFAP5, and S100A1 were up-regulated in the endometrium of obese patients. These genes are mainly involved in chemokine, cytokine, and immune system activity and in the structural extracellular matrix and protein-binding molecular functions. CONCLUSION(S): Obesity is associated with significant endometrial transcriptomic differences as compared with non-obese subjects. Altered endometrial gene expression in obese patients may contribute to the lower implantation rates and increased miscarriage rates seen in obese infertile patients. CLINICAL TRIAL REGISTRATION NUMBER: NCT02205866.
引用
- Comstock IA, Diaz-Gimeno P, Cabanillas S, et al. Does an increased body mass index affect endometrial gene expression patterns in infertile patients? A functional genomics analysis. Fertil Steril. 2016. PMID: 27919438. doi:10.1016/j.fertnstert.2016.11.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。